The AKT signaling pathway is also important for modulating the sensitivity of renal cancer cells to TKIs, and combination with AKT inhibitor treatment improved the anticancer effect of TKIs in ccRCC 28, 39. This evidence concerns the gene AKT1 and renal carcinoma.